BMO
AMPE

Beck Mack & Oliver’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Beck Mack & Oliver’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-42
Closed -$5K – 228
2018
Q4 		$5K Buy
+42
New +$6.45K ﹤0.01% 219

Other funds holding AMPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Beck Mack & Oliver's AMPE Position: Q1 2019 in Review

Beck Mack & Oliver sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2019, closing a stake of 42 shares — an estimated $5K sold.

Beck Mack & Oliver first reported a position in AMPE in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 84 funds tracked by Wall St. Rank hold AMPE as of Q1 2019.

  • Beck Mack & Oliver reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
  • Beck Mack & Oliver sold 42 Ampio Pharmaceuticals Inc. shares in Q1 2019, an estimated $5K.
  • Beck Mack & Oliver first reported a position in Ampio Pharmaceuticals Inc. in Q4 2018 and held it in 1 quarter.
  • Beck Mack & Oliver's Ampio Pharmaceuticals Inc. position peaked at $5K in Q4 2018.
  • 84 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2019.

Based on Beck Mack & Oliver's 13F filing for Q1 2019, filed 2 May 2019.